Skip to Content

Fibrokit

Fibromyalgia is a chronic condition that affects 6% of the global population. It is characterised by constant, widespread pain that is, in many cases, debilitating. This disease is not yet fully characterised at the molecular level, complicating its diagnosis and treatment.

To support healthcare professionals in both diagnosis and treatment, Fibrokit provides an innovative solution.
This molecular test is based on the analysis of diagnostic biomarkers from blood and stool samples, enabling a more precise way to diagnose and address the disease.

Fibrokit Benefits

1

Accelerate fibromyalgia diagnosis

2

Identify specific health imbalances to personalise patient treatment

3

Predict the effectiveness of different ongoing therapies

4

Evaluate potential causes of pain, fatigue, and gastrointestinal discomfort

5

Establish key parameters for monitoring patient treatment and condition progression

Recommendations

Fibrokit is recommended for patients experiencing:



Widespread chronic pain


Recurrent joint stiffness


Constant fatigue and sleep disturbances


Gastrointestinal disorders


Cognitive difficulties or 'fibro fog'"


Chronic pelvic pain and dysmenorrhea


Family history of fibromyalgia

Test procedure


Sample collection

Two peripheral blood tubes (drawn by a healthcare professional) and two stool samples (collected at home by the patient) are required.


Preservation

Keep both tubes containing the blood sample at 4°C and the stool samples properly refrigerated until shipment.


Results

Results will be delivered within 20 business days from the arrival of the samples at the laboratory, along with a detailed report.

The Fibrokit test provides a more comfortable and fulfilling life for those affected by fibromyalgia.

Brochure with exclusive information for healthcare professionals

Folleto con información exclusiva para profesionales:

Fibrokit Brochure